Morphle Labs is powering clinical microscopy with Imaging Hardware (Whole slide scanners) & AI driven cancer diagnosis workflows.

Basic Information

Bengaluru, Karnataka based Morphle Labs powers pathology labs, cancer hospitals, and research institutes with AI-enabled robotic plug-and-play whole slide scanners that guarantee superior image quality, quick scanning, and cutting-edge image analysis tools at competitive pricing. Their robotic microscopes’ features robust scanning - agnostic of pre-analytic variation, image analysis, tele-reporting, and digital archiving, improve efficiency and save time, effort, and resources at every stage of the workflow. They are committed to ensuring that the benefits of the latest technology innovations improve the lives of patients, pathologists, researchers, and the medical community the world over. Their Salient Features: Robust Scanning - 0% slide reject rate for slide preparation defects like uneven cut tissue sections, DPX bubbles, projecting out cover slips & more; Affordable Variants - Starting at $20,000 Morphle microscope slide scanners deliver image quality and speed comparable to other microscope scanners 5X the cost; Sharp Image Quality - View crisp scans at a digitally enabled 80X zoom; Seamless Tele-reporting - Designed and built for telepathology. Open link and start reporting; Lossless Compression - Compact 0.1 to 0.5 Gb file size with special lossless compression; Plug & Play unboxing - On-demand calibration support & training; Risk-free return policy - Return your digital pathology scanner for a full refund within 60 days of purchase; Morphle Warranty - On break downs from normal usage within 1 year, they will replace it for free. Their scanners have been stress-tested to last 3 years of full-time use. See more

Legal Name

:

Morphle Labs Pvt. Ltd

Headquarters

:

Bengaluru, Karnataka, India

Business Model

:

B2B 

Founding Date

:

2020

No. of Employees

:

21 to 40

Core Team

:
1.

Rohit Hiwale

Co-Founder & CEO

2.

Anchit Navelkar

Co-Founder & CTO

Timeline
2020
true
Jan | Company Incorporation
Company Incorporation

Target Market

B2B

We are working towards democratizing digital pathology for pathology labs, cancer hospitals and research institutes

Client Segment

:

HealthTech / MedTech / Healthcare

Target Companies

:

Medium Enterprise, Large Enterprise

Target Geography

:

Global

Funding

Total Funding

$1.2M

Investors

:

1.

Y Combinator